DAREON ™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With Topotecan
Condition: Small Cell Lung Carcinoma (SCLC) Interventions: Drug: BI 764532; Drug: Topotecan Sponsor: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Research | Small Cell Lung Cancer | Study